Search

Search Constraints

You searched for: Author/Creator Atmaca, Akin

Search Results

1. Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis. (May 2022)

2. Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial. Issue 7 (July 2016)

4. Prognostic and predictive value of estrogen receptor 1 expression in completely resected non‐small cell lung cancer. Issue 8 (7th May 2013)

5. Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild‐Type Non‐Small Cell Lung Cancer. (12th April 2019)

6. The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non‐small cell lung cancer. Issue 10 (14th November 2013)